Aclarubicin Not Yet Recruiting Phase 2 Trials for Elderly Patients / Acute Myeloid Leukemia / Newly Diagnosed Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT04254640Efficacy and Safety of Cladribine in Combination With CAG in Newly Diagnosed Unfit Patients With AML